INTEGRASE STRAND TRANSFER INHIBITOR (INSTI)
Isentress is a prescription drug approved by the Food and Drug Administration (FDA) to treat HIV-1 infection in combination with other antiretroviral medications. Isentress is approved for use in people four weeks and older. Isentress is also referred to by its drug name, Raltegravir, and by the abbreviation RAL.
Isentress is an antiviral medication of the integrase strand transfer inhibitor (INSTI) class. Isentress is believed to work by preventing HIV from replicating in cells.
How do I take it?
Prescribing information states that Isentress is taken twice daily.
Isentress comes in tablet, chewable tablet, and oral suspension forms.
The FDA-approved label for Isentress lists common side effects including headache, dizziness, nausea, fatigue, and diarrhea.
Rare but serious side effects listed for Isentress include severe hypersensitivity reactions.
For more details about this treatment, visit:
Overview of HIV Treatments – AIDS.gov